Digital ECG data and AI will fuel pharma’s next drug development and... Discover how the integration of ECG data and AI is transforming the pharmaceutical industry, revolutionising drug development and commercialisation.
R&D Patterns of behaviour: Using AI-based algorithms to improve ... For those of us old enough to remember ringing in the year 2000, current concerns that artificial intelligence (AI) may usher in the end of the world as we know it may call to mind the fear
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.